{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:21:22Z","timestamp":1777792882419,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7348","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1038\/nature10003","type":"journal-article","created":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T04:39:19Z","timestamp":1305088759000},"page":"523-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":882,"title":["Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine"],"prefix":"10.1038","volume":"473","author":[{"given":"Scott G.","family":"Hansen","sequence":"first","affiliation":[]},{"given":"Julia C.","family":"Ford","sequence":"additional","affiliation":[]},{"given":"Matthew S.","family":"Lewis","sequence":"additional","affiliation":[]},{"given":"Abigail B.","family":"Ventura","sequence":"additional","affiliation":[]},{"given":"Colette M.","family":"Hughes","sequence":"additional","affiliation":[]},{"given":"Lia","family":"Coyne-Johnson","sequence":"additional","affiliation":[]},{"given":"Nathan","family":"Whizin","sequence":"additional","affiliation":[]},{"given":"Kelli","family":"Oswald","sequence":"additional","affiliation":[]},{"given":"Rebecca","family":"Shoemaker","sequence":"additional","affiliation":[]},{"given":"Tonya","family":"Swanson","sequence":"additional","affiliation":[]},{"given":"Alfred W.","family":"Legasse","sequence":"additional","affiliation":[]},{"given":"Maria J.","family":"Chiuchiolo","sequence":"additional","affiliation":[]},{"given":"Christopher L.","family":"Parks","sequence":"additional","affiliation":[]},{"given":"Michael K.","family":"Axthelm","sequence":"additional","affiliation":[]},{"given":"Jay A.","family":"Nelson","sequence":"additional","affiliation":[]},{"given":"Michael A.","family":"Jarvis","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Piatak","sequence":"additional","affiliation":[]},{"given":"Jeffrey D.","family":"Lifson","sequence":"additional","affiliation":[]},{"given":"Louis J.","family":"Picker","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,5,11]]},"reference":[{"key":"BFnature10003_CR1","first-page":"3","volume-title":"Persistent Viral Infections","author":"K Grovit-Ferbas","year":"1999","unstructured":"Grovit-Ferbas, K., Pappas, T. & O\u2019Brien, W. A. in Persistent Viral Infections (eds Ahmed, R. & Chen, A. I. ) 3\u201345 (John Wiley & Sons, 1999)"},{"key":"BFnature10003_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nri1706","volume":"5","author":"AT Haase","year":"2005","unstructured":"Haase, A. T. Perils at mucosal front lines for HIV and SIV and their hosts. Nature Rev. Immunol. 5, 783\u2013792 (2005)","journal-title":"Nature Rev. Immunol."},{"key":"BFnature10003_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nri2357","volume":"8","author":"PJ Goulder","year":"2008","unstructured":"Goulder, P. J. & Watkins, D. I. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nature Rev. Immunol. 8, 619\u2013630 (2008)","journal-title":"Nature Rev. Immunol."},{"key":"BFnature10003_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature08757","volume":"464","author":"AT Haase","year":"2010","unstructured":"Haase, A. T. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464, 217\u2013223 (2010)","journal-title":"Nature"},{"key":"BFnature10003_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nm.1935","volume":"15","author":"SG Hansen","year":"2009","unstructured":"Hansen, S. G. et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nature Med. 15, 293\u2013299 (2009)","journal-title":"Nature Med."},{"key":"BFnature10003_CR6","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1038\/nm1212","volume":"11","author":"HL Robinson","year":"2005","unstructured":"Robinson, H. L. & Amara, R. R. T cell vaccines for microbial infections. Nature Med. 11, S25\u2013S32 (2005)","journal-title":"Nature Med."},{"key":"BFnature10003_CR7","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.1073\/pnas.0802203105","volume":"105","author":"BF Keele","year":"2008","unstructured":"Keele, B. F. et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl Acad. Sci. USA 105, 7552\u20137557 (2008)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature10003_CR8","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1073\/pnas.95.15.8869","volume":"95","author":"TW Chun","year":"1998","unstructured":"Chun, T. W. et al. Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection. Proc. Natl Acad. Sci. USA 95, 8869\u20138873 (1998)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature10003_CR9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1073\/pnas.94.2.640","volume":"94","author":"MF Bachmann","year":"1997","unstructured":"Bachmann, M. F., Kundig, T. M., Hengartner, H. & Zinkernagel, R. M. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without \u201cmemory T cells\u201d? Proc. Natl Acad. Sci. USA 94, 640\u2013645 (1997)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature10003_CR10","doi-asserted-by":"publisher","first-page":"9293","DOI":"10.1073\/pnas.96.16.9293","volume":"96","author":"AF Ochsenbein","year":"1999","unstructured":"Ochsenbein, A. F. et al. A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. Proc. Natl Acad. Sci. USA 96, 9293\u20139298 (1999)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature10003_CR11","doi-asserted-by":"publisher","first-page":"15547","DOI":"10.1128\/JVI.79.24.15547-15555.2005","volume":"79","author":"DR Casimiro","year":"2005","unstructured":"Casimiro, D. R. et al. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag. J. Virol. 79, 15547\u201315555 (2005)","journal-title":"J. Virol."},{"key":"BFnature10003_CR12","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1126\/science.1124226","volume":"312","author":"NL Letvin","year":"2006","unstructured":"Letvin, N. L. et al. Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 312, 1530\u20131533 (2006)","journal-title":"Science"},{"key":"BFnature10003_CR13","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.1128\/JVI.00171-06","volume":"80","author":"NA Wilson","year":"2006","unstructured":"Wilson, N. A. et al. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J. Virol. 80, 5875\u20135885 (2006)","journal-title":"J. Virol."},{"key":"BFnature10003_CR14","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1128\/JVI.02392-06","volume":"81","author":"TC Friedrich","year":"2007","unstructured":"Friedrich, T. C. et al. Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication. J. Virol. 81, 3465\u20133476 (2007)","journal-title":"J. Virol."},{"key":"BFnature10003_CR15","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1084\/jem.20081524","volume":"205","author":"MR Reynolds","year":"2008","unstructured":"Reynolds, M. R. et al. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J. Exp. Med. 205, 2537\u20132550 (2008)","journal-title":"J. Exp. Med."},{"key":"BFnature10003_CR16","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1128\/JVI.77.8.4938-4949.2003","volume":"77","author":"A Shen","year":"2003","unstructured":"Shen, A. et al. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy. J. Virol. 77, 4938\u20134949 (2003)","journal-title":"J. Virol."},{"key":"BFnature10003_CR17","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1128\/JVI.00840-09","volume":"83","author":"JB Dinoso","year":"2009","unstructured":"Dinoso, J. B. et al. A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. J. Virol. 83, 9247\u20139257 (2009)","journal-title":"J. Virol."},{"key":"BFnature10003_CR18","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1128\/JVI.02356-09","volume":"84","author":"TW North","year":"2010","unstructured":"North, T. W. et al. Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J. Virol. 84, 2913\u20132922 (2010)","journal-title":"J. Virol."},{"key":"BFnature10003_CR19","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1097\/00002030-199901140-00001","volume":"13","author":"L Ruiz","year":"1999","unstructured":"Ruiz, L. et al. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue. AIDS 13, F1\u2013F8 (1999)","journal-title":"AIDS"},{"key":"BFnature10003_CR20","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1128\/JVI.02165-06","volume":"81","author":"JN Blankson","year":"2007","unstructured":"Blankson, J. N. et al. Isolation and characterization of replication-competent human immuno-deficiency virus type 1 from a subset of elite suppressors. J. Virol. 81, 2508\u20132518 (2007)","journal-title":"J. Virol."},{"key":"BFnature10003_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00002030-200301030-00008","volume":"17","author":"PA Anton","year":"2003","unstructured":"Anton, P. A. et al. Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects. AIDS 17, 53\u201363 (2003)","journal-title":"AIDS"},{"key":"BFnature10003_CR22","doi-asserted-by":"crossref","unstructured":"Montefiori, D. C. Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr. Protoc. Immunol. 12, Unit 12.11. (2005)","DOI":"10.1002\/0471142735.im1211s64"},{"key":"BFnature10003_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0684.2005.00128.x","volume":"34","author":"AN Cline","year":"2005","unstructured":"Cline, A. N., Bess, J. W., Piatak, M., Jr & Lifson, J. D. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J. Med. Primatol. 34, 303\u2013312 (2005)","journal-title":"J. Med. Primatol."},{"key":"BFnature10003_CR24","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.2353\/ajpath.2008.070967","volume":"172","author":"S Venneti","year":"2008","unstructured":"Venneti, S. et al. Longitudinal in vivo positron emission tomography imaging of infected and activated brain macrophages in a macaque model of human immunodeficiency virus encephalitis correlates with central and peripheral markers of encephalitis and areas of synaptic degeneration. Am. J. Pathol. 172, 1603\u20131616 (2008)","journal-title":"Am. J. Pathol."},{"key":"BFnature10003_CR25","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1084\/jem.20090356","volume":"206","author":"A Okoye","year":"2009","unstructured":"Okoye, A. et al. Profound CD4+\/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis. J. Exp. Med. 206, 1575\u20131588 (2009)","journal-title":"J. Exp. Med."},{"key":"BFnature10003_CR26","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1128\/JVI.00893-08","volume":"82","author":"M Vaccari","year":"2008","unstructured":"Vaccari, M. et al. Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency. J. Virol. 82, 9629\u20139638 (2008)","journal-title":"J. Virol."},{"key":"BFnature10003_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4049\/jimmunol.168.1.29","volume":"168","author":"CJ Pitcher","year":"2002","unstructured":"Pitcher, C. J. et al. Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168, 29\u201343 (2002)","journal-title":"J. Immunol."},{"key":"BFnature10003_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1126\/science.280.5362.427","volume":"280","author":"RS Veazey","year":"1998","unstructured":"Veazey, R. S. et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280, 427\u2013431 (1998)","journal-title":"Science"},{"key":"BFnature10003_CR29","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.4049\/jimmunol.164.11.6015","volume":"164","author":"JE Schmitz","year":"2000","unstructured":"Schmitz, J. E. et al. Simian immunodeficiency virus (SIV)-specific CTL are present in large numbers in livers of SIV-infected rhesus monkeys. J. Immunol. 164, 6015\u20136019 (2000)","journal-title":"J. Immunol."},{"key":"BFnature10003_CR30","doi-asserted-by":"publisher","first-page":"5073","DOI":"10.1128\/JVI.77.9.5073-5083.2003","volume":"77","author":"WL Chang","year":"2003","unstructured":"Chang, W. L. & Barry, P. A. Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis. J. Virol. 77, 5073\u20135083 (2003)","journal-title":"J. Virol."},{"issue":"39","key":"BFnature10003_CR31","doi-asserted-by":"publisher","first-page":"6742","DOI":"10.1016\/j.vaccine.2010.12.056","volume":"29","author":"Viraj Kulkarni","year":"2011","unstructured":"Kulkarni, V. R. et al. Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques. Vaccine doi:10.1016\/j.vaccine.2010.12.056.","journal-title":"Vaccine"},{"key":"BFnature10003_CR32","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.1128\/JVI.79.13.8480-8492.2005","volume":"79","author":"M Rosati","year":"2005","unstructured":"Rosati, M. et al. DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J. Virol. 79, 8480\u20138492 (2005)","journal-title":"J. Virol."},{"key":"BFnature10003_CR33","doi-asserted-by":"publisher","first-page":"15831","DOI":"10.1073\/pnas.0902628106","volume":"106","author":"M Rosati","year":"2009","unstructured":"Rosati, M. et al. DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge. Proc. Natl Acad. Sci. USA 106, 15831\u201315836 (2009)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature10003_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0092-8674(92)90213-V","volume":"68","author":"MA Rosenfeld","year":"1992","unstructured":"Rosenfeld, M. A. et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143\u2013155 (1992)","journal-title":"Cell"},{"key":"BFnature10003_CR35","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","volume":"70","author":"N Mittereder","year":"1996","unstructured":"Mittereder, N., March, K. L. & Trapnell, B. C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70, 7498\u20137509 (1996)","journal-title":"J. Virol."},{"key":"BFnature10003_CR36","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1128\/JVI.01396-06","volume":"81","author":"A Shen","year":"2007","unstructured":"Shen, A. et al. Novel pathway for induction of latent virus from resting CD4+ T cells in the simian immunodeficiency virus\/macaque model of human immunodeficiency virus type 1 latency. J. Virol. 81, 1660\u20131670 (2007)","journal-title":"J. Virol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature10003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature10003","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature10003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:51:58Z","timestamp":1684417918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature10003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":36,"journal-issue":{"issue":"7348","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["BFnature10003"],"URL":"https:\/\/doi.org\/10.1038\/nature10003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.10541958.14521054","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.10541958.11392057","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.10541958.793528450","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.10541958.793494225","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.10541958.11720056","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.10541958.12226054","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"1 December 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"[Competing financial interests: OHSU has licensed CMV vector technology, for which L.J.P., M.A.J. and J.A.N. are inventors, to the International AIDS Vaccine Initiative (IAVI).]","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}